Thompson tapped for study
by MBJ Staff
Published: March 14,2010
Hattiesburg Clinic vascular surgeon Keith Thompson, D.O., F.A.C.O.S., has been selected to serve as a principle investigator in a nationwide Food and Drug Administration approved clinical study evaluating the minimally invasive repair of abdominal aortic aneurysms. The study sponsored by Endologix, of Irvine, Calif., involves 19 centers across the country including facilities such as: Cleveland Clinic in Cleveland, Ohio; Stanford University in Stanford, Calif.; Northwestern University in Chicago; Dartmouth in Hanover, N.H.; and, the University of Texas Southwestern in Dallas.
Thompson has been a proponent of the minimally invasive treatment of aneurysms and the minimally invasive repair of severe traumatic vascular injuries, having performed the first surgery in the state for thoracic aortic stent-graft repair for traumatic injury in 2005. Shortly after the surgery, Thompson published a report in Mississippi Medical Journal, and now several physicians across the state now offer this life-saving treatment.
Thompson is board certified in vascular surgery, and is a member of the Society for Vascular Surgery and Southern Association for Vascular Surgery. He is in vascular practice with Lewis Hatten, M.D., and Brian Sellers, D.O., at Hattiesburg Clinic.
To sign up for Mississippi Business Daily Updates, click here.
Twang & Tourism: The Country Music Trail
FOLLOW THE MBJ ON TWITTERMy Tweets
Top Posts & Pages
- DAVID DALLAS: Mr. McDaniel goes to Washington
- Moon River Foods creating 100 jobs in Mississippi Delta
- Judge to hear from True the Vote as McDaniel attempts to overturn loss to Cochran
- Google chooses Mad Genius as example of Internet use
- Weyerhaeuser investing $57M to modernize lumber mill
- Two BancorpSouth mergers delayed by federal inquiries
- Health officials identify another case of chikungunya virus
- Biloxi council approves $29M contract for baseball stadium construction
- Wasted away — Margaritaville in Biloxi to close by Sept. 19
- Cochran continues to question EPA over new regulations